NCT05053412View on ClinicalTrials.gov

HELIO Liver Test Performance Study in China (HEPATIC)

CompletedOBSERVATIONAL
Enrollment

1,556

Participants

Timeline

Start Date

September 1, 2021

Primary Completion Date

March 1, 2024

Study Completion Date

May 31, 2024

Conditions
Hepatocellular Carcinoma and Liver Disease
Interventions
DIAGNOSTIC_TEST

Helio Liver Test

A Helio Liver Test is used as the basis of performance evaluation for specificity and sensitivity for all patients enrolled in the study.

Trial Locations (2)

Unknown

People's Liberation Army General Hospital, Beijing

The First Affiliated Hospital of Guangzhou Medical University, Beijing

Sponsors

Lead Sponsor

Helio Genomics
All Listed Sponsors
collaborator

Helio Health Inc., Irvine, CA

UNKNOWN

lead

Helio Genomics

INDUSTRY